Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Breast Cancer

  Free Subscription


9 AJR Am J Roentgenol
1 Am J Clin Oncol
1 Am J Clin Pathol
1 Am J Surg
1 Ann Surg Oncol
3 BMC Cancer
1 Br J Cancer
3 Breast Cancer
4 Breast Cancer Res
8 Breast Cancer Res Treat
1 Breast J
1 Cancer Cell
1 Cancer Lett
2 Clin Breast Cancer
1 Gene
1 Int J Radiat Oncol Biol Phys
1 J Biol Chem
1 J Natl Cancer Inst
1 Mod Pathol
1 NPJ Breast Cancer
3 Oncogene
3 PLoS One
3 Proc Natl Acad Sci U S A
1 Radiology
2 Radiother Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. EDMONDS CE, Lamb LR, Mercaldo SF, Sippo DA, et al
    Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
    AJR Am J Roentgenol. 2019 Dec 4:1-9. doi: 10.2214/AJR.19.21778.
    PubMed         Abstract available

    CT-Guided Seed Localization in the Breast and Axilla.
    AJR Am J Roentgenol. 2019 Oct 31:1-4. doi: 10.2214/AJR.19.21885.
    PubMed         Abstract available

  3. LEE CS, Monticciolo DL, Moy L
    Screening Guidelines Update for Average-Risk and High-Risk Women.
    AJR Am J Roentgenol. 2020;214:316-323.
    PubMed         Abstract available

  4. DESTOUNIS SV, Santacroce A, Arieno A
    Update on Breast Density, Risk Estimation, and Supplemental Screening.
    AJR Am J Roentgenol. 2020;214:296-305.
    PubMed         Abstract available

  5. SARDANELLI F, Cozzi A, Trimboli RM, Schiaffino S, et al
    Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
    AJR Am J Roentgenol. 2019 Dec 4:1-4. doi: 10.2214/AJR.19.21988.
    PubMed         Abstract available

    Breast Pain, A Common Grievance: Guidance to Radiologists.
    AJR Am J Roentgenol. 2020;214:259-264.
    PubMed         Abstract available

  7. HUPPE AI, Brem RF
    Minimally Invasive Breast Procedures: Practical Tips and Tricks.
    AJR Am J Roentgenol. 2020;214:306-315.
    PubMed         Abstract available

  8. COHEN EO, Tso HH, Leung JWT
    Multiple Bilateral Circumscribed Breast Masses Detected at Imaging: Review of Evidence for Management Recommendations.
    AJR Am J Roentgenol. 2019 Dec 11:1-6. doi: 10.2214/AJR.19.22061.
    PubMed         Abstract available

  9. LINDEN OE, Hayward JH, Price ER, Kelil T, et al
    Utility of Diagnostic Mammography as the Primary Imaging Modality for Palpable Lumps in Women With Almost Entirely Fatty Breasts.
    AJR Am J Roentgenol. 2020 Feb 5:1-7. doi: 10.2214/AJR.19.21760.
    PubMed         Abstract available

    Am J Clin Oncol

  10. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed         Abstract available

    Am J Clin Pathol

  11. ALGHAMDI SA, Krishnamurthy K, Garces Narvaez SA, Algashaamy KJ, et al
    Low-Grade Ductal Carcinoma In Situ.
    Am J Clin Pathol. 2020;153:360-367.
    PubMed         Abstract available

    Am J Surg

  12. BAYARD S, Susick L, Kyei I, Chen Y, et al
    Brief report: Global health initiatives and breast oncology capacity-building in Africa.
    Am J Surg. 2020;219:563-565.
    PubMed         Abstract available

    Ann Surg Oncol

  13. SCHWARZ J, Schmidt H
    Correction to: Technology for Intraoperative Margin Assessment in Breast Cancer.
    Ann Surg Oncol. 2020 May 13. pii: 10.1245/s10434-020-08573.
    PubMed         Abstract available

    BMC Cancer

  14. OMARINI C, Piacentini F, Sperduti I, Barbolini M, et al
    Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and
    BMC Cancer. 2020;20:418.
    PubMed         Abstract available

  15. ALFARSI LH, El Ansari R, Craze ML, Masisi BK, et al
    PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer.
    BMC Cancer. 2020;20:425.
    PubMed         Abstract available

  16. MERY B, Fouilloux A, Rowinski E, Catella-Chatron J, et al
    Cardiovascular disease events within 5 years after a diagnosis of breast cancer.
    BMC Cancer. 2020;20:337.
    PubMed         Abstract available

    Br J Cancer

  17. LAMEIJER JRC, Voogd AC, Pijnappel RM, Setz-Pels W, et al
    Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands.
    Br J Cancer. 2020 May 11. pii: 10.1038/s41416-020-0870.
    PubMed         Abstract available

    Breast Cancer

  18. IWAMOTO T, Fujisawa T, Shien T, Araki K, et al
    The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs.
    Breast Cancer. 2020 May 11. pii: 10.1007/s12282-020-01095.
    PubMed         Abstract available

  19. KUBO M, Kumamaru H, Isozumi U, Miyashita M, et al
    Annual report of the Japanese Breast Cancer Society registry for 2016.
    Breast Cancer. 2020 May 11. pii: 10.1007/s12282-020-01081.
    PubMed         Abstract available

  20. BALTRES A, Al Masry Z, Zemouri R, Valmary-Degano S, et al
    Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer.
    Breast Cancer. 2020 May 8. pii: 10.1007/s12282-020-01100.
    PubMed         Abstract available

    Breast Cancer Res

  21. GALLAGHER EJ, Fei K, Feldman SM, Port E, et al
    Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.
    Breast Cancer Res. 2020;22:40.
    PubMed         Abstract available

  22. MARTINEZ-SAEZ O, Chic N, Pascual T, Adamo B, et al
    Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
    Breast Cancer Res. 2020;22:45.
    PubMed         Abstract available

  23. KOLBERG-LIEDTKE C, Oleg G, Fred H, Friedrich F, et al
    Association of TILs with clinical parameters, Recurrence Score(R) results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
    Breast Cancer Res. 2020;22:47.
    PubMed         Abstract available

  24. SKRIVER SK, Jensen MB, Knoop AS, Ejlertsen B, et al
    Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.
    Breast Cancer Res. 2020;22:46.
    PubMed         Abstract available

    Breast Cancer Res Treat

  25. KALINSKY K, Accordino MK, Hosi K, Hawley JE, et al
    Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.
    Breast Cancer Res Treat. 2020 May 14:1-4. doi: 10.1007/s10549-020-05667.

  26. KALINSKY K, Accordino MK, Hosi K, Hawley JE, et al
    Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.
    Breast Cancer Res Treat. 2020 May 14. pii: 10.1007/s10549-020-05667.

  27. ZHOU L, Chen B, Sheng L, Turner A, et al
    The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis.
    Breast Cancer Res Treat. 2020 May 13. pii: 10.1007/s10549-020-05669.
    PubMed         Abstract available

  28. ROJAS KE, Manasseh DM, Rojas M, Mattocks A, et al
    The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer.
    Breast Cancer Res Treat. 2020 May 12. pii: 10.1007/s10549-020-05666.
    PubMed         Abstract available

  29. SAITO T, Ono R, Kono S, Asano M, et al
    Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study.
    Breast Cancer Res Treat. 2020 May 12. pii: 10.1007/s10549-020-05668.
    PubMed         Abstract available

  30. DU F, Wang W, Wang Y, Li M, et al
    Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer.
    Breast Cancer Res Treat. 2020 May 11. pii: 10.1007/s10549-020-05648.
    PubMed         Abstract available

  31. EZRATTY C, Vang S, Brown J, Margolies LR, et al
    Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts.
    Breast Cancer Res Treat. 2020 May 11. pii: 10.1007/s10549-020-05652.
    PubMed         Abstract available

  32. UMAMAHESWARAN G, Kadambari D, Muthuvel SK, Kalaivani S, et al
    Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity.
    Breast Cancer Res Treat. 2020 May 8. pii: 10.1007/s10549-020-05656.
    PubMed         Abstract available

    Breast J

  33. RAVINDHRAN B, Attigere Math H, Chalegere M, Raheem A, et al
    The efficacy of frozen gel packs on postoperative pain, and NSAID or narcotic use in patients undergoing surgery for axillary node-positive breast cancer.
    Breast J. 2020 May 10. doi: 10.1111/tbj.13871.

    Cancer Cell

  34. SAVAS P, Loi S
    Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2020;37:623-624.
    PubMed         Abstract available

    Cancer Lett

  35. HE Z, Khatib AM, Creemers JWM
    Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer.
    Cancer Lett. 2020 May 7. pii: S0304-3835(20)30229.
    PubMed         Abstract available

    Clin Breast Cancer

  36. SOMASHEKHAR SP, Kumar CR, Ashwin KR, Zaveri SS, et al
    Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
    Clin Breast Cancer. 2020 Apr 6. pii: S1526-8209(20)30069.
    PubMed         Abstract available

  37. CHANDARANA M, Tan YY, Kirby R, Jafferbhoy S, et al
    Patient-reported Upper Limb Function After Sentinel Lymph Node Biopsy for Breast Cancer: A Prospective Observational Study.
    Clin Breast Cancer. 2020 Apr 10. pii: S1526-8209(20)30070.
    PubMed         Abstract available


  38. JIA R, Zhao H, Jia M
    Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA.
    Gene. 2020;750:144757.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  39. KEILTY D, Namini SN, Swain M, Maganti M, et al
    Patterns of recurrence and predictors of survival in breast cancer patients treated with neoadjuvant chemotherapy, surgery, and radiation.
    Int J Radiat Oncol Biol Phys. 2020 May 11. pii: S0360-3016(20)31121.
    PubMed         Abstract available

    J Biol Chem

    Targeting the polyamine pathway-"a means" to overcome chemoresistance in triple-negative breast cancer.
    J Biol Chem. 2020;295:6278-6279.
    PubMed         Abstract available

    J Natl Cancer Inst

  41. SCHETTINI F, Giudici F, Giuliano M, Cristofanilli M, et al
    Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis.
    J Natl Cancer Inst. 2020 May 14. pii: 5837114. doi: 10.1093.
    PubMed         Abstract available

    Mod Pathol

  42. ALSALEEM MA, Ball G, Toss MS, Raafat S, et al
    A novel prognostic two-gene signature for triple negative breast cancer.
    Mod Pathol. 2020 May 13. pii: 10.1038/s41379-020-0563.
    PubMed         Abstract available

    NPJ Breast Cancer

  43. KOS Z, Roblin E, Kim RS, Michiels S, et al
    Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
    NPJ Breast Cancer. 2020;6:17.
    PubMed         Abstract available


  44. JIANG M, Zhang W, Zhang R, Liu P, et al
    Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer.
    Oncogene. 2020 May 12. pii: 10.1038/s41388-020-1322.
    PubMed         Abstract available

  45. MEYER-SCHALLER N, Tiede S, Ivanek R, Diepenbruck M, et al
    A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells.
    Oncogene. 2020 May 14. pii: 10.1038/s41388-020-1326.
    PubMed         Abstract available

  46. SHMULEVICH R, Nissim TB, Wolf I, Merenbakh-Lamin K, et al
    Klotho rewires cellular metabolism of breast cancer cells through alteration of calcium shuttling and mitochondrial activity.
    Oncogene. 2020 May 12. pii: 10.1038/s41388-020-1313.
    PubMed         Abstract available

    PLoS One

  47. AHN S, Chung YR, Seo AN, Kim M, et al
    Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
    PLoS One. 2020;15:e0233037.
    PubMed         Abstract available

  48. LINDENBERG M, van Beek A, Retel V, van Duijnhoven F, et al
    Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.
    PLoS One. 2020;15:e0232690.
    PubMed         Abstract available

  49. ANDERSON O, Guttilla Reed IK
    Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
    PLoS One. 2020;15:e0233187.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  50. LIN CW, Xie J, Zhang D, Han KH, et al
    Immunity against cancer cells may promote their proliferation and metastasis.
    Proc Natl Acad Sci U S A. 2020;117:426-431.
    PubMed         Abstract available

  51. PUGACHEVA EM, Kubo N, Loukinov D, Tajmul M, et al
    CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention.
    Proc Natl Acad Sci U S A. 2020;117:2020-2031.
    PubMed         Abstract available

  52. WINKLER I, Bitter C, Winkler S, Weichenhan D, et al
    Identification of Ppargamma-modulated miRNA hubs that target the fibrotic tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:454-463.
    PubMed         Abstract available


  53. GASTOUNIOTI A, Kasi CD, Scott CG, Brandt KR, et al
    Evaluation of LIBRA Software for Fully Automated Mammographic Density Assessment in Breast Cancer Risk Prediction.
    Radiology. 2020 May 12:192509. doi: 10.1148/radiol.2020192509.
    PubMed         Abstract available

    Radiother Oncol

  54. FASTNER G, Gaisberger C, Kaiser J, Scherer P, et al
    ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer.
    Radiother Oncol. 2020 May 12. pii: S0167-8140(20)30240.
    PubMed         Abstract available

  55. QUIRK S, Grendarova P, Phan T, Conroy L, et al
    A retrospective analysis to demonstrate achievable dosimetry for the left anterior descending artery in left-sided breast cancer patients treated with radiotherapy.
    Radiother Oncol. 2020;148:167-173.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.